Evidence map›Paper›PMID 25035957›Full record

ArticleImmunity2014

Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.

André Ballesteros-Tato, Beatriz León, Byung O Lee, Frances E Lund, Troy D Randall

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 59 citations in OpenAlex.

  1. BATF3 regulates differentiation of CD8Life science alliance · 2026
    Article
  2. Review
  3. CD27 and ICOS as Targets of PD-1/PD-L1 Signaling to Regulate Resident Memory CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Emerging concepts in PD-1 checkpoint biology.Seminars in immunology · 2021
    Review
  14. Tissue-resident CD4Science immunology · 2021
    Article
  15. Review
  16. Tissue-resident CD8Science immunology · 2020
    Article
  17. Article
  18. Article
  19. Discipline in Stages: Regulating CD8Frontiers in immunology · 2020
    Review
  20. HumanClinical & translational immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

André Ballesteros-TatoDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Beatriz LeónDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Byung O LeeVaccine Research Institute of San Diego, San Diego, CA 92109, USA.
Frances E LundDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Troy D RandallDepartment of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: randallt@uab.edu.
University of Alabama at Birmingham · USVaccine Research Institute of San Diego · US

Funding

ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Unique Aspects of Respiratory ImmunityR01HL069409 · NHLBI · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2001 to 2015
$5.3M
Generation of effective memory CD8 T cells to influenzaR01AI061511 · NIAID · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2005 to 2009
$1.8M
Function of NALT in nasal immunization to heterotypic strains of influenzaR01AI072689 · NIAID · UNIVERSITY OF ROCHESTER · PI RANDALL, TROY D · 2007 to 2010
$1.5M
NHLBI NIH HHS HL069409NHLBI NIH HHS R01 HL069409NIAID NIH HHS AI061511NIAID NIH HHS AI072689NIAID NIH HHS R01 AI061511NIAID NIH HHS R01 AI072689NIAMS NIH HHS AR048311NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

Memory CD8(+) T cells are programmed during the primary response for robust secondary responsiveness. Here we show that CD8(+) T cells responding to different epitopes of influenza virus received qualitatively different signals during the primary response that altered their secondary responsiveness. Nucleoprotein (NP)-specific CD8(+) T cells encountered antigen on CD40-licensed, CD70-expressing, CD103(-)CD11b(hi) dendritic cells (DCs) at later times in the primary response. As a consequence, they maintained CD25 expression and responded to interleukin-2 (IL-2) and CD27, which together programmed their robust secondary proliferative capacity and interferon-γ (IFN-γ)-producing ability. In contrast, polymerase (PA)-specific CD8(+) T cells did not encounter antigen-bearing, CD40-activated DCs at later times in the primary response, did not receive CD27 and CD25 signals, and were not programmed to become memory CD8(+) T cells with strong proliferative and cytokine-producing ability. As a result, CD8(+) T cells responding to abundant antigens, like NP, dominated the secondary response.

Indexed as

Adoptive TransferAnimalsAntigen PresentationAntigens, CDCD11b AntigenCD27 LigandCD40 AntigensCD8-Positive T-LymphocytesCells, CulturedDendritic CellsDNA-Directed RNA PolymerasesEpitopes, T-LymphocyteHistocompatibility Antigens Class IImmunologic MemoryInfluenza A virusIntegrin alpha Chainsalpha E integrinsAntigens, CDCD11b AntigenCD27 LigandCD40 AntigensDNA-Directed RNA PolymerasesEpitopes, T-LymphocyteHistocompatibility Antigens Class IIl2ra protein, mouseIntegrin alpha ChainsInterferon-gammaInterleukin-2Interleukin-2 Receptor alpha SubunitMinor Histocompatibility AntigensMr1 protein, mouseNucleoproteinsTumor Necrosis Factor Receptor Superfamily, Member 7Viral Core Proteins

Identifiers

PMID25035957
PMCPMC4233138
OpenAlexW1969031853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.